Drug Control Division

  
The Drug Control Division works to protect the health and safety of Connecticut residents by regulating all persons and firms involved in the distribution of all legal drugs, medical devices and cosmetics in Connecticut. The Division oversees Connecticut licensing for pharmacies, pharmacists, controlled substance providers and laboratories, pharmacy technicians, manufacturers and wholesalers of drugs, cosmetics and medical devices and medical marijuana.  The Drug Control Division is also responsible for the Prescription Monitoring Program.

 

Licenses, Registrations, Permits, etc. - Find all of the types of Licenses, Registration, Permits that are a part of the Drug Control Division  and more.

Commission of Pharmacy - Find meeting minutes, members and other pharmacy related information and more.

Pharmacy Complaints - Learn how to file a complaint about a pharmacy.

Preventing Prescription/Medication Errors  - Find tips for protecting yourself against prescription/medication errors.

Prescription Monitoring Program - Find information about the Connecticut Prescription Monitoring and Reporting System and more.

Medical Marijuana Program - Registration, practitioners information, qualifying conditions, frequently asked questions and more.

Registrant Resources and Guidance Documents - Find documents that may be help for different disciplines regulated by the Drug Control Division.

Law Enforcement Resources - Find general information about medication, charges and more.

Statutes and Regulations - Find law information regarding the laws that pertain to the Drug Control Division.

Certificate of Free Sale - Click here for the certificate of free sale documents required by the Drug Control Division.

 

Latest News/Quick Resource

New: Return of Prescription Drugs to Pharmacies

New:Epinephrine in Authorized Entities

Updated:Suspicious Order Monitoring

Electronic Prescribing of Controlled Substances

Resources:


New Laws

  • Public Act 19-191 An Act Addressing Opioid Use
    • Section 1: Pharmacist Counseling
    • Section 3: Pharmacy Technician Delegate in the Connecticut Prescription Monitoring and Reporting System
    • Section 4: Suspicious Order Monitoring
    • Section 6: Pain Agreements/Care Plan for Treatment of Pain with Opioids for Greater than 12 weeks
    • Section 7: Naloxone at Institutions of Higher Education
  • Public Act 19-19 An Act Concerning Epinephrine Auto Injectors (Effective From Passage)
  • Public Act 19-177 An Act Making Changes to Department of Consumer Protection Enforcement Statutes
    • Section 28: Sterile Compounding
    • Section 29: Pharmacy to report legal action commenced by federal or state agency
    • Section 30: Classification of Connecticut Controlled Substances
    • Section 31: Marijuana Products Schedule Changes
  • Public Act 19-98 An Act Concerning the Scope of Practice of Advanced Practice Registered Nurses
    • Section 22 and 23: Advanced practice registered nurses and collaborative drug therapy management
  • Public Act 19-38 An Act Concerning Increasing the Penalties for Sale of Fentanyl
  • Public Act 19-13 An Act Concerning the Sale of Cigarettes, Tobacco Products, Electronic Nicotine Delivery Systems and Vapor Products to Persons Under Age Twenty-One
  • Public Act 18-166 (Effective 7/1/2018)
    • Section 2: Self and Family Prescribing of Controlled Substances Limitation
    • Section 3: Naloxone Distribution Agreements
  •  Public Act 18-148 (Effective 7/1/18) 
    • Section 1: Telehealth - expansion to add controlled substances for a psychiatric disability or substance use disorder
    • Section 2: Prevents practitioners using telehealth from receiving a waiver from electronic prescribing of controlled substances
  • Public Act 18-74 (Effective 10/1/2018) - Biologic products 
  • Public Act 18-16 (Effective 1/1/19) 
    • Section 1: Penalty per violation of the chapter
    • Section 2: Fees for filing changes for Non-Resident Pharmacies
    • Section 3: Suspicious order reporting for Manufacturers and Wholesalers
    • Section 4: Annually controlled substance inventory
    • Section 5: Perpetual inventory for Schedule II medications with monthly reconciliation
    • Section 6: Sterile compounding 
  • HYDROCODONE MOVES TO SCHEDULE II
    • Prescriptions issued before October 6, 2014:   October 6, 2014/April 8, 2015 :  Any prescriptions for HCPs that are issued before October 6, 2014, and authorized for refilling, may be dispensed in accordance with 21 CFR 1306.22-1306.23, 1306.25, and 1306.27, if such dispensing occurs before April 8, 2015.
    • Prescriptions issued on or after October 6, 2014 October 6: 2014 :  No prescription for HCPs issued on or after October 6, 2014 shall authorize any refills. 

 Source:  Federal Register

Authority:  21 U.S.C. 829(a); 21 CFR part 1306 and subpart C of 21 CFR part 1311.   

Educational Resources for Law Enforcement, First Responders and Healthcare Personnel: